• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Pericardial lymphosarcoma associated with pericardial effusion

April 1, 2004
Ronald Lyman, DVM, Dipl. ACVIM

Pericardial effusion (PE) is in the list of differential diagnoses when a patient presents with weakness or collapse, weak pulses and muffled heart sounds.

Pericardial effusion (PE) is in the list of differential diagnoses when a patient presents with weakness or collapse, weak pulses and muffled heart sounds.

Ronald Lyman DVM, Dipl. ACVIM

The clinician may elect to perform radiographs, which reveal a globoid cardiac silhouette, followed by an ultrasound examination defining the fluid within the pericardial cavity.

Advertisement

Common diagnoses

At this point, some of the common diagnoses, including hemangiosarcoma with hemorrhage, idiopathic and infectious pericarditis, quickly come to mind. However, recently investigators from Tufts and the University of Wisconsin-Madison reported on a series of cases in dogs where the cause of the PE was lymphosarcoma (MacGregor et al in the Proceedings of the 21st ACVIM Forum, 2003, pg 952). Of course, the definitive long-term treatment of lymphosarcoma is markedly different than the more commonly considered causes of PE.

These nine cases all presented with signs relating to their pericardial disease. They had collapse episodes, and most had ascites. Blood tests were not helpful in reaching the diagnosis. Following the imaging by radiographs and ultrasound, pericardiocentesis and cytological analysis revealed the presence of neoplastic lymphocytes. Three of the patients were treated with combination chemotherapies which included doxorubicin, resulting in survivals of 157, >328, and >659 days, respectively. Survival times are comparable with multicentric lymphosarcoma if cardiac issues can be successfully managed.

Be aware

Thus, the clinician should be aware that pericardial effusion may be the only presenting sign of cardiac or pericardial lymphosarcoma.

In humans it is noted that sometimes biopsy of the heart or pericardium may be necessary when cytology does not provide a conclusive diagnosis (Gowda et al in Angiology 599-604 Sept.-Oct. 2003). One should consider this option in refractory PE of uncertain etiology in our veterinary patients.

A pericardial window may be opened by thoracotomy if necessary to improve cardiovascular hemodynamics (Stepian et al J Small Animal Practice 2000, pgs 342-347). Alternatively, the biopsy may be obtained and window opened via a videothoracoscopic procedure (Kovak et al, JAVMA 2002, Volume 221, No. 7).


Advertisement

Latest News

Thriving when life is hard

Hospital design expert shares his favorite design element

Updated EquiTrace app integrates wth HISA Portal

San Francisco SPCA receives $100k grant from San Francisco Foundation

View More Latest News
Advertisement